Pain Management and Surgical Devices Global Market - Forecast to 2025

Published by IQ4I on 12th December 2018 | Ref: 1111553 | This Report Is In Stock

$4950 | Single User
$6750 | Site License
$9000 | Enterprise License
$4950 | Single User
$6750 | Site License
$9000 | Enterprise License

Introduction

Pain is a debilitating condition, which can arise from arthritis, cancer, fibromyalgia and trauma, which includes neuropathic pain and nociceptive pain. This report focuses on treating various pain conditions with electrotherapy devices, ablation devices and surgical procedures. Electrotherapy devices include Spinal cord stimulator, peripheral nerve stimulator, TENS and NMES devices. These devices use electricity to treat pain by blocking the pain signals passing from nerve to brain. Surgical procedures such as kyphoplasty and vertebroplasty are used to treat pain caused by degenerative disc disease, whereas ablation procedures such as Radiofrequency ablation and Cryoablation are used to treat chronic pain and cancer pain by damaging pain causing nerve tissue. Ablation procedure damages the nerve that causes the pain and stops the transmission of pain signals to the brain. Several other devices like spacers, screws and artificial discs are used to treat back pain and neck pain caused by degenerative disc disease.

According to IQ4I analysis, the pain management and surgical devices global market is expected to grow at a high single digit CAGR to reach ,824.7 million by 2025. The pain management and surgical devices market is mainly segmented by products, treatment type, application, end-users and by geography.

Based on the products market is segmented into pain devices and pain surgery, among this pain devices accounted the largest revenue in 2018 and is expected to grow at a high single digit CAGR from 2018 to 2025. Pain devices segment is further classified into internal pain devices and external pain devices. Among the internal pain devices, spinal cord stimulator accounted the largest revenue in 2018 and is projected to grow at a high single digit CAGR from 2018 to 2025. Among the external pain devices, TENS is accounted for largest revenue in 2018 and is expected to grow at a low single digit CAGR from 2018 to 2025, other external pain device segment include ultrasound therapy, photobiomodulation therapy, microwave therapy, short wave therapy, vegus nerve stimulation therapy and is expected to grow at a low single digit CAGR from 2018 to 2025. Pain surgery segment is divided into Kyphoplasty and vertebroplasty, fixation devices, artificial disc replacement and ablation. Among this kyphoplasty and vertebroplasty accounted the largest revenue in 2018 and is expected to grow at a mid single digit CAGR from 2018 to 2025, artificial disc replacement is projected to grow at a high single digit CAGR from 2018 to 2025. In pain surgery, ablation segment is further classified into radiofrequency ablation and cryoablation. Among this, radiofrequency ablation accounted the largest revenue and is projected to grow at a mid single digit CAGR from 2018 to 2025. Cryoablation is expected to grow at a high single digit CAGR from 2018 to 2025.

Based on the treatment type, pain management and surgical devices are classified into Invasive and non invasive. Among this, invasive devices accounted the largest revenue in 2018 and expected to grow at a high single digit CAGR from 2018 to 2025.

The applications segment in the pain management and surgical device market is classified into neuropathic pain, cancer pain, failed back surgery syndrome (FBSS), musculoskeletal disorder (MSD) and other pain, Among these applications, MSD holds the highest share in 2018, and expected to grow at a high single digit CAGR from 2018 to 2025, due to increase in incidence of musculoskeletal disorders.

Based on end-users, pain management and surgical devices market is segmented into hospitals, ambulatory surgical centers, pain management centers and others. In this segment, hospitals held the highest share in 2018, and expected to grow at a high single digit CAGR from 2018 to 2025.

Pain management and surgical devices geographic market is segmented into four major regions namely North America, Europe, Asia Pacific and Rest of World (ROW). North American region commanded the largest revenue in 2018 and expected to grow at a mid single digit CAGR. However, Asia-Pacific is expected to grow at high single digit CAGR from 2018 to 2025.

Major players in pain management devices and surgical devices are Abbot Laboratories (U.S.), Boston Scientific (U.S.), Medtronic Inc. (Ireland), Avanos Medical Inc. (Halyard health Inc.) (U.S.), Nevrocorp (U.S.), Nuvectra corporation (U.S.), Stryker Corporation (U.S.), Johnson and Johnson (DePuy synthes), (U.S.), Merit medicals (U.S.), DJO Finance Ltd. (Chattanooga) (U.S.).

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

• North America

o U.S.

o Rest of North America

• Europe

o Germany

o France

o U.K.

o Rest of Europe

• Asia-Pacific

o Japan

o China

o India

o Rest of APAC

• Rest of the World (RoW)

o Brazil

o Rest of Latin America

o Middle East and Others

Table of Contents

1 EXECUTIVE SUMMARY 25

2 INTRODUCTION 30

2.1 KEY TAKEAWAYS 30

2.2 SCOPE OF THE REPORT 31

2.3 REPORT DESCRIPTION 31

2.4 MARKETS COVERED 34

2.5 STAKEHOLDERS 35

2.6 RESEARCH METHODOLOGY 36

3 MARKET ANALYSIS 45

3.1 INTRODUCTION 45

3.2 MARKET SEGMENTATION 46

3.3 FACTORS INFLUENCING MARKET 48

3.4 REGULATORY AFFAIRS 55

3.5 PATENT TRENDS 60

3.6 TECHNOLOGICAL ADVANCEMENTS 62

3.7 PORTER’S FIVE FORCE ANALYSIS 65

3.8 SUPPLY CHAIN ANALYSIS 68

3.9 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 72

3.10 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET PENETRATION AND NUMBER OF UNIT SOLD 81

3.11 PAIN MANAGEMNENT AND SURGICAL DEVICES NUMBER OF UNITS

BY REGION 83

(2017-2025) (NO’S) 83

BY REGION 85

3.12 PAIN MANAGEMENT AND SURGICAL DEVICES COMPANY COMPARISON

TABLE BY PRODUCTS 86

4 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET,

BY PRODUCT 97

4.1 INTRODUCTION 97

4.2 PAIN DEVICES 102

4.3 PAIN SURGERY 138

5 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET,

BY TREATMENT TYPE 155

5.1 INTRODUCTION 155

5.2 INVASIVE PAIN MANAGEMENT AND SURGICAL DEVICES 158

5.3 NON-INVASIVE PAIN MANAGEMENT AND SURGICAL DEVICES 161

6 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET,

BY APPLICATION 164

6.1 INTRODUCTION 164

6.2 NEUROPATHIC PAIN 167

6.3 CANCER PAIN 169

6.4 FAILED BACK SURGERY SYNDROME (FBSS) 171

6.5 MUSCULOSKELETAL DISORDERS (MSD) 173

6.6 OTHER PAIN 175

7 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET,

BY END-USERS 177

7.1 INTRODUCTION 177

7.2 HOSPITALS 180

7.3 AMBULATORY SURGERY CENTER 182

7.4 PAIN MANAGEMENT CENTERS & OTHERS 184

8 REGIONAL ANALYSIS 186

8.1 INTRODUCTION 186

8.2 NORTH AMERICA 190

8.3 EUROPE 213

8.4 APAC 244

8.5 ROW 275

9 COMPETITIVE LANDSCAPE 302

9.1 INTRODUCTION 302

9.2 APPROVALS 303

9.3 NEW PRODUCT LAUNCH 305

9.4 MERGERS AND ACQUISITIONS 307

10 MAJOR COMPANIES 310

10.1 ABBOTT LABORATORIES 310

10.2 AVANOS MEDICAL, INC. (HALYARD HEALTH, INC.) 318

10.3 BOSTON SCIENTIFIC CORPOARTION 324

10.4 DJO GLOBAL 332

10.5 JOHNSON AND JOHNSON 339

10.6 MEDTRONIC, PLC 349

10.7 MERIT MEDICALS SYSTEM INC. 357

10.8 NEVROCORP 364

10.9 NUVECTRA 370

10.10 STRYKER CORPORATION 377

Additional Details

Publisher

IQ4I

Publisher Information

Reference

1111553 |

Number of Pages

385

Report Format

PDF

This report is published by IQ4I

Download Free Report Summary PDF

Pain Management and Surgical Devices Global Market - Forecast to 2025 [Updated: 12-12-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.